Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity
Clinical trial NCT02124902 · TERMINATED
Trial details
- NCT number
- NCT02124902
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-07
- Primary completion
- 2021-11-10
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.